SENSEX NIFTY
Oct 03, 2011, 05.43 PM IST | Source: CNBC-TV18

FCCB case: Bombay HC adjourns Wockhardt hearing to Oct 11

Pharma major Wockhardt now has additional time on its hands to finalise a formal repayment plan for its overseas bond holders.

After the Bell

Excerpts from After the Bell on CNBC-TV18 Watch the full show »

Pharma major Wockhardt now has additional time on its hands to finalise a formal repayment plan for its overseas bond holders.

The company has total dues of Rs 358 crore it was supposed to revert to the Bombay High Court with a detailed plan by October 3.

It now has extra time as the court today adjourned the case to October 11.

A group of bondholders led by the bond trustee of the Bank of New York Mellon, Sun Pharma Global and hedge fund QVT besides some creditors had taken Wockhardt to court, filing a wind-up petition, after the company defaulted on repayment of its USD 110-million FCCBs, in 2009.

Wockhardt stock price

On November 28, 2014, Wockhardt closed at Rs 843.60, up Rs 16.20, or 1.96 percent. The 52-week high of the share was Rs 886.50 and the 52-week low was Rs 336.60.


The company's trailing 12-month (TTM) EPS was at Rs 38.12 per share as per the quarter ended September 2014. The stock's price-to-earnings (P/E) ratio was 22.13. The latest book value of the company is Rs 85.16 per share. At current value, the price-to-book value of the company is 9.91.

Set email alert for

ADS BY GOOGLE

video of the day

India inflation to drop at startling levels in 2015: Walker

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.